{
    "Trade/Device Name(s)": [
        "OSOM Influenza A&B Test",
        "OSOM\u00ae Influenza A&B Test"
    ],
    "Submitter Information": "Genzyme Corporation",
    "510(k) Number": "K051244",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031899"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "February 13, 2006",
    "Summary Letter Received Date": "February 15, 2006",
    "Submission Date": "May 13, 2005",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigens",
        "Influenza B viral nucleoprotein antigens"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for OSOM Influenza A&B Test, a lateral flow immunoassay for qualitative detection of influenza A and B viral antigens from nasal swabs",
    "Indications for Use Summary": "Intended for the qualitative detection of influenza A and B viral nucleoprotein antigens from nasal swab specimens in symptomatic patients to aid rapid differential diagnosis; not intended for detection of influenza C, negative results are presumptive and should be confirmed by cell culture",
    "fda_folder": "Microbiology"
}